Showing results (281-290 of 438) with videos related to

Sort By:
Pageof 44
Ejhaem|July 18, 2022
Longitudinal health-related quality of life in first-line treated patients with chronic lymphocytic leukemia: Results from the Connect® CLL RegistryJeff P Sharman, Kim Cocks, Chadi Nabhan, et al.
Blood|February 8, 2017
Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphomaAriela Noy, Sven de Vos, Catherine Thieblemont, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 21, 2018
Prognostic Testing Patterns and Outcomes of Chronic Lymphocytic Leukemia Patients Stratified by Fluorescence In Situ Hybridization/Cytogenetics: A Real-world Clinical Experience in the Connect CLL RegistryAnthony Mato, Chadi Nabhan, Neil E Kay, et al.
Blood|October 6, 2021
Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trialsCarla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, et al.
Leukemia & Lymphoma|May 16, 2014
Intensive chemotherapy and consolidation with high dose therapy and autologous stem cell transplant in patients with mantle cell lymphomaLoretta J Nastoupil, Pareen J Shenoy, Alex Ambinder, et al.
Eclinicalmedicine|August 20, 2024
Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trialAshwath Gurumurthi, Collin K Chin, Lei Feng, et al.
Oncology (Williston Park, N.Y.)|October 19, 2013
ACR Appropriateness Criteria: Localized nodal indolent lymphomaBradford S Hoppe, David C Hodgson, Ranjana Advani, et al.
Cancer|November 28, 2018
Safety and survival outcomes for bloodless transplantation in patients with myelomaNisha S Joseph, Jonathan L Kaufman, Lawrence H Boise, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 11, 2013
Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemiaChris L Pashos, Christopher R Flowers, Neil E Kay, et al.
British Journal of Haematology|August 8, 2015
A phase II study of bortezomib added to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients with previously untreated indolent non-Hodgkin's lymphomaJonathon B Cohen, Jeffrey M Switchenko, Jean L Koff, et al.
Pageof 44